AstraZeneca Hit With Second EU Lawsuit on Vaccine Supplies
By Mauro Orru
The European Union is launching a second lawsuit against
AstraZeneca PLC to scrutinize whether the company breached the
advance purchase agreement with the bloc over vaccine supplies.
A spokesman for the European Commission, the EU's executive arm,
said Tuesday that while the latest suit is still aimed at ensuring
the supply of doses from AstraZeneca, its objective is to probe
whether there has been a violation of the advance purchase
"We believe that AstraZeneca has indeed not respected the terms
and conditions of the advance purchase agreement and in the context
of this process we ask the court to follow us in our reasoning,"
the spokesman said.
The announcement comes just weeks after the EU filed the first
suit against the company. The EU and AstraZeneca have been at
loggerheads since the company said earlier this year that it would
only be able to deliver a fraction of the up to 400 million doses
it was contracted to deliver to the bloc by the middle of the
The spokesman said the bloc is requesting that an order for the
delivery of doses, including through the imposition of
AstraZeneca didn't respond to a request for comment.
Write to Mauro Orru at email@example.com; @MauroOrru94
(END) Dow Jones Newswires
May 11, 2021 09:44 ET (13:44 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.